The primacy of IL-6 in IPS?

作者: Takanori Teshima

DOI: 10.1182/BLOOD-2015-02-629816

关键词: MEDLINEImmunologyInterleukin 6Lung pathologyInterleukinIdiopathic pneumonia syndromeMedicineTransplantationStem cell

摘要: In this issue of Blood, Varelias and colleagues demonstrate a central role interleukin (IL)-6 in idiopathic pneumonia syndrome (IPS) after allogeneic stem cell transplantation (SCT) both mice humans.

参考文章(9)
Antiopi Varelias, Kate H. Gartlan, Ellen Kreijveld, Stuart D. Olver, Mary Lor, Rachel D. Kuns, Katie E. Lineburg, Bianca E. Teal, Neil C. Raffelt, Melody Cheong, Kylie A. Alexander, Motoko Koyama, Kate A. Markey, Elise Sturgeon, Justine Leach, Pavan Reddy, Glen A. Kennedy, Gregory A. Yanik, Bruce R. Blazar, Siok-Keen Tey, Andrew D. Clouston, Kelli P. A. MacDonald, Kenneth R. Cooke, Geoffrey R. Hill, Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation Blood. ,vol. 125, pp. 2435- 2444 ,(2015) , 10.1182/BLOOD-2014-07-590232
Gregory A. Yanik, Stephan A. Grupp, Michael A. Pulsipher, John E. Levine, Kirk R. Schultz, Donna A. Wall, Bryan Langholz, Christopher C. Dvorak, Keith Alangaden, Rakesh K. Goyal, Eric S. White, Jennifer M. Collura, Micah A. Skeens, Saada Eid, Elizabeth M. Pierce, Kenneth R. Cooke, TNF-Receptor Inhibitor Therapy for the Treatment of Children with Idiopathic Pneumonia Syndrome. A Joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521) Biology of Blood and Marrow Transplantation. ,vol. 21, pp. 67- 73 ,(2015) , 10.1016/J.BBMT.2014.09.019
Angela C. Burman, Tatjana Banovic, Rachel D. Kuns, Andrew D. Clouston, Amanda C. Stanley, Edward S. Morris, Vanessa Rowe, Helen Bofinger, Renae Skoczylas, Neil Raffelt, Olivier Fahy, Shaun R. McColl, Christian R. Engwerda, Kelli P. A. McDonald, Geoffrey R. Hill, IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract Blood. ,vol. 110, pp. 1064- 1072 ,(2007) , 10.1182/BLOOD-2006-12-063982
Motoko Koyama, Rachel D Kuns, Stuart D Olver, Neil C Raffelt, Yana A Wilson, Alistair L J Don, Katie E Lineburg, Melody Cheong, Renee J Robb, Kate A Markey, Antiopi Varelias, Bernard Malissen, Günter J Hämmerling, Andrew D Clouston, Christian R Engwerda, Purnima Bhat, Kelli P A MacDonald, Geoffrey R Hill, Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease Nature Medicine. ,vol. 18, pp. 135- 142 ,(2012) , 10.1038/NM.2597
Kenneth R. Cooke, Geoffrey R. Hill, Armin Gerbitz, Lester Kobzik, Thomas R. Martin, James M. Crawford, Joanne P. Brewer, James L. M. Ferrara, Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation. ,vol. 70, pp. 272- 279 ,(2000) , 10.1097/00007890-200007270-00006
Pawel Muranski, Nicholas P. Restifo, Essentials of Th17 cell commitment and plasticity. Blood. ,vol. 121, pp. 2402- 2414 ,(2013) , 10.1182/BLOOD-2012-09-378653
Angela Panoskaltsis-Mortari, Matthias Griese, David K. Madtes, John A. Belperio, Imad Y. Haddad, Rodney J. Folz, Kenneth R. Cooke, An Official American Thoracic Society Research Statement: Noninfectious Lung Injury after Hematopoietic Stem Cell Transplantation: Idiopathic Pneumonia Syndrome American Journal of Respiratory and Critical Care Medicine. ,vol. 183, pp. 1262- 1279 ,(2011) , 10.1164/RCCM.2007-413ST
David L. Porter, Bruce L. Levine, Michael Kalos, Adam Bagg, Carl H. June, Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia The New England Journal of Medicine. ,vol. 365, pp. 725- 733 ,(2011) , 10.1056/NEJMOA1103849
Glen A Kennedy, Antiopi Varelias, Slavica Vuckovic, Laetitia Le Texier, Kate H Gartlan, Ping Zhang, Gethin Thomas, Lisa Anderson, Glen Boyle, Nicole Cloonan, Justine Leach, Elise Sturgeon, Judy Avery, Stuart D Olver, Mary Lor, Ashish K Misra, Cheryl Hutchins, A James Morton, Simon TS Durrant, Elango Subramoniapillai, Jason P Butler, Cameron I Curley, Kelli P A MacDonald, Siok-Keen Tey, Geoffrey R Hill, Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. Lancet Oncology. ,vol. 15, pp. 1451- 1459 ,(2014) , 10.1016/S1470-2045(14)71017-4